ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed
Alexander T. El Gammal
Matched on OpenAlex author ID A5002593017. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper
Papers 3
- Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer. Last author DOI 10.1002/ijc.32567↗
- Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and immunohistochemistry. Co-author DOI 10.1002/jso.23826↗
- COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. Co-author DOI 10.1186/s12943-015-0386-1↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Maximilian Bockhorn · 3 shared papers, 2015–2020 · strength 0.17
- Paper Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer. DOI 10.1002/ijc.32567↗
- Paper Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and … DOI 10.1002/jso.23826↗
- Paper COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. DOI 10.1186/s12943-015-0386-1↗
- Jakob Robert Izbicki · 3 shared papers, 2015–2020 · strength 0.17
- Paper Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer. DOI 10.1002/ijc.32567↗
- Paper Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: analysis of CD G870A polymorphism, FISH and … DOI 10.1002/jso.23826↗
- Paper COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. DOI 10.1186/s12943-015-0386-1↗
- Gerrit Wolters‐Eisfeld · 2 shared papers, 2015–2020 · strength 0.12
- Bianca T. Hofmann · 2 shared papers, 2015–2020 · strength 0.12
- Cenap Güngör · 2 shared papers, 2015–2020 · strength 0.12
- Leonie Konczalla · 1 shared paper, 2020 · strength 0.08
- Udo Schumacher · 1 shared paper, 2020 · strength 0.08
- Faik Güntac Uzunoglu · 1 shared paper, 2020 · strength 0.08
- Michael Fabian Nentwich · 1 shared paper, 2015 · strength 0.05
- Kai A. Bachmann · 1 shared paper, 2015 · strength 0.05
- Oliver Mann · 1 shared paper, 2015 · strength 0.05
- Yogesh Kumar Vashist · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.